ARCHIVES

As Zeneca Buys Salick, Implications For Oncology Managed Care Uncertain

This article is from The Cancer Letter archive.

Vol. 23 No. 13 | April 4, 1997

Download PDF Visit The Full Archive

Related Articles

Congress Insists On No Downward Negotiations; NCI May Drop 2000 To 300 Grants In FY 1991

November 9, 1990

Committee Recommends FDA Approval Of Three New Drugs For Cancer Treatment

March 27, 1998

Phase III Data of Antibody-Drug Conjugate Shows PFS Increase in HER2+ Disease

June 29, 2012

IARC Director Denies NCI Staff Interference With Monograph

May 28, 1982

Women Who Concieve Using Fertility Drugs Have a Higher Risk Of Breast Cancer Than Non-Users

July 27, 2012

“Our Job Is to Be The One Agency That Speaks To Cancer”

October 28, 1994